Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects ― A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER…

Overview of attention for article published in Circulation Journal, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 1 news story.

This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.